Search Weight Loss Topics:


Page 3«..2345..1020..»


Dec 9

How to Reverse Visceral Fat, Say Experts Eat This Not That – Eat This, Not That

Ever notice how the last place we tend to lose fat is in the belly? Abdominal fat oftentimes seems impossible to lose and chances are it's because it's visceral fat"a type of body fat that's stored within the abdominal cavity between your vital organs: liver, intestines, pancreas, etc," says Jillian Michaelscreator of The Fitness App by Jillian Michaels. While it can be challenging to lose, there are ways to help reverse visceral fat and get rid of the stubborn excess weight. Eat This, Not That! Health talked to Michaels, a personal trainer, nutritionist, life coach and former Biggest Loser fitness instructor, who explained everything to know about visceral fat. Read onand to ensure your health and the health of others, don't miss these Sure Signs You've Already Had COVID.

In order to know how much visceral fat to lose, you should know how much you have first. Michaels explains how to measure. "Outside of an MRI or CT scan the best way to know if you have visceral fat is the waist to hip ratio calculation. You simply

In women, a waist circumference of 35 inches or larger is generally considered a sign of excess visceral fat. In men, it's 40."

Visceral fat can be difficult to lose. Michaels says, "There are several reasons why visceral fat is difficult to lose, but they all tie back to hormone imbalances. Visceral fat gets stored like all fat because we are eating too much and moving too little. However, the body first aims to store the fat subcutaneously (just under the skin). When we take on too much excess body fat it then gets stored viscerally. The habits that created this excess fat in the first place have hormonal consequences that then beget a bit of a catch 22.

For example, visceral fat is linked to insulin resistance from too much sugar and not enough fitness, elevated cortisol levels from too much stress, and the secretion of excess inflammatory proteins called cytokines. When it comes to metabolism (the rate we burn calories, when, how and where we store fat) are directly connected to our hormone balance. Once insulin resistance begins and cortisol levels surge it makes it that much harder to get our metabolism out of fat storage mode and into fat burning mode. Plus, the habits/lifestyle that got us into this position in the first place are often the hardest to break. From desk jobs and sugar addiction to long work days and age-related hormonal shifts it can seem like an uphill battle."

RELATED: 5 Ways to Prevent Alzheimer's, Says Dr. Sanjay Gupta

You can absolutely lose visceral fat with diet and lifestyle changes. Michaels says, "there is a lot we can do. Let's sensitize your body to insulin again by cutting out processed carbs and refined sugars, so nothing white. No white flour and no white sugar. So avoid eating processed salty or sweet snacks. Choose whole grains, fruits, vegetables, beans, legumes instead."

RELATED: The #1 Reason You Can't Remember Something, According to Science

Michaels states, "Drink your water and keep sodium intake at bay. Try to avoid over 2000mg a day unless you sweat a ton and are very athletic and generally people with excess visceral fat aren't engaging in intense fitness training. Studies have linked excess sodium intake with increased insulin resistance, metabolic syndrome, and glucocorticoid production. An easy way to do this is to choose reduced sodium products, up your water intake, and don't salt your food."

RELATED: The #1 Habit That Ages Your Skin Faster

Michaels stresses how important it is to stay active. "Start moving your body. Exercise is the best way to get the body sensitized to insulin and reverse type two diabetes. If you have the ability, techniques like HIIT training and Strength training are the most effective for this. The Fitness App has many programs for this including HIIT workouts for beginners so you can be effective and safe."

RELATED: 5 Warning Signs Your Brain is in Trouble

Michaels says, "Get your 8 hours of shuteye. Lack of sleep increases our hunger hormones and dampens our satiety hormones making us feel the need to eat more. In addition, it inhibits our HGH production, which is a key hormone for muscle maintenance and fat metabolism. Lack of sleep is also associated with higher cortisol levels which is a hormone notorious for belly fat storage. So make sure to shut off the screens and get 7 to 8 hours of shut eye every night."

RELATED: How Can You Avoid COVID? A Virus Expert Weighs In

Taking a break from life's daily stresses isn't just good for us mentally, but physically as well. Michaels reveals: "Take your vacations, manage your stress levels, try meditating anything that helps you manage stress. Cortisol is our fight or flight hormone and when we are constantly stressed it's constantly surging so work to find your chill!"

Michaels says, "Up your vitamin C intake! Early studies have shown that vitamin C can help reduce our cortisol secretion. So consider a supplement or just eat your citrus!"

RELATED: The #1 Worst Supplements That Are a Rip-Off

"Last, we want to do what is going to help us reduce body fat overall and that is eating less calories and moving more often," Michaels explains. "Fat is stored energy and the calories in our food are units of energy. No matter how "healthy" a food is you can still eat too much of it. Take an organic avocado for example it's loaded with vitamins, minerals, and healthy fats with likely zero chemical residue from pesticides, fungicides, herbicides etc. But it's very high in calories. If you eat too many calories than your body is burning in a day you will store that energy in your fat cells. So be mindful of your overall calorie intake. Cut the booze. Booze dampens fat metabolism by up to 73%. And as I mentioned repeatedly EXERCISE it burns calories and helps to bring our hormones back into balance." And to get through this pandemic at your healthiest, don't miss these 35 Places You're Most Likely to Catch COVID.

Read the rest here:
How to Reverse Visceral Fat, Say Experts Eat This Not That - Eat This, Not That


Nov 21

Human growth hormone (hGH): How to boost it and illegal use – INSIDER

Human growth hormone (hGH) is a key hormone that helps maintain muscle tissue and is often associated with enhanced athletic performance, increased bone density, and reduced body fat.

This has led some athletic communities to attempt doping with hGH to improve strength and performance. That's why you may sometimes hear about illegal hGH use.

Note: HGH is prohibited by the World Anti-Doping Agency. And even though growth hormone is abused in competitive athletics, its benefits in a healthy, adult population are uncertain, according to a 2018 study.

However, if your doctor prescribes you hGH for hGH deficiency, then it's perfectly legal to use. There are also ways to increase hGH levels without medical aid, though they are not very effective long-term.

Here we discuss why some people have low hGH, how to boost hGH levels, and common side effects.

Human growth hormone (hGH) is a hormone you produce naturally. In childhood, it plays a key role in your physical growth and development.

However, hGH is also important in adulthood, helping maintain tissue and organ function. You can't get hGH from food, so if you're hGH deficient, it's important to see a doctor.

A doctor will typically prescribe injections of a synthetic version of the hormone called recombinant growth hormone (rhGH) to combat symptoms of low hGH.

HGH is produced by the pituitary gland, a small pea-sized organ located at the base of your brain. When that gland doesn't produce enough hGH, you're at risk of low hGH levels.

Children who are deficient in hGH may have short stature or stunted growth. Treatment requires daily injections of rhGH and typically continues until the child has stopped growing, around age 16 to 18, says Alan Rogol, MD, PhD, a pediatric endocrinologist and professor emeritus at the University of Virginia.

In adults, low hGH is often due to damage to the pituitary gland or the hypothalamus, a part of the brain that controls the pituitary gland. Damage is often from tumors in the area of the pituitary gland and hypothalamus, Rogol says.

Symptoms of adult growth hormone deficiency include:

To test for growth hormone deficiency, the first step is a blood test called IGF-1 to screen for a deficiency, and then a test called a growth hormone stimulation test, Rogol says.

Because you can't take growth hormone legally unless you're being treated for a deficiency, people may want to try to boost hGH levels naturally for its purported benefits.

Certain activities, such as exercise, do boost hGH levels, but the effects may not be significant enough to see the desired effects, Rogol says. "It's a controversial issue," he says.

Moreover, it's unclear from present research whether these changes are long-lasting or only temporary. So, whether these results are clinically relevant is unclear and more long-term research is needed.

With that in mind, here are some ways you may be able to boost hGH naturally, according to Shawn Arent, PhD, professor and the chair of the Department of Exercise Science at the University of South Carolina and an ACSM fellow:

Fasting and avoiding sugars can also affect hGH levels, but the effects are complicated because of how growth hormone interplays with other hormones and activities, and exercise will have a much greater effect, Arent says.

Last, there are supplements you can buy that claim to stimulate the natural release of hGH. For example, some supplements contain the amino acid L-arginine, which "some studies ... show that L-arginine can increase growth hormone. Whether it's meaningful or not, though, is pretty debatable," says Arent.

Moreover, a 2008 review looked at how exercise and L-arginine supplementation affected growth hormone responses and found that L-arginine increases growth hormone levels, but that exercise increases them more dramatically.

Although hGH has important benefits for people who take it to treat a deficiency, hGH also has some potential long-term side effects, according to the FDA, including:

Other side effects can include:

Growth hormone injections are effective in treating people with hGh deficiency, but other ways of taking the hormone are illegal.

By exercising and getting a good night's sleep, you may help boost your hGH levels, but this effect may only be temporary and not lead to any significant long-term changes.

If you're looking to boost hGH to build muscle or lose fat, eating a well-balanced diet and incorporating high-intensity exercise and weight training may be a better approach.

Follow this link:
Human growth hormone (hGH): How to boost it and illegal use - INSIDER


Nov 8

Physiology, Growth Hormone – StatPearls – NCBI Bookshelf

Introduction

Human growth hormone (HGH), also known as somatotropin, is a 191 amino acid single-chain polypeptide produced by somatotropic cells within the anterior pituitary gland. As its name implies, scientists originally found it to be responsible forgrowth regulation during childhood. However, research has determined that HGH is also responsible for the regulation of many of the bodys other basal metabolic functions and operates as an acute phase stress reactant.[1][2]

Human growth hormone is produced viathe anterior pituitary of the brain in the acidophilic, somatotrophic cells. Its production is tightly regulated through several complex feedback mechanisms in response to stress, exercise, nutrition, sleep, and growth hormone itself. The primary regulation factors are growth hormone-releasing hormone (GHRH) produced in the hypothalamus, somatostatin, produced in various tissues throughout the body, and ghrelin, which is produced in the gastrointestinal tract. GHRH functions to promote HGH production and release. Somatostatin inhibits the release of GHRH as well as the HGH release response to GHRH stimulus and increases in hypoglycemia. Ghrelin is a hormone produced by the stomach as part of the hunger response. Functionally, the ghrelin response is protective against hypoglycemia. When elevated, ghrelin binds to somatotrophs to stimulate HGH secretion.Insulin-like growth factor-1 also acts to inhibit HGH by both directly inhibiting somatotrophic HGH release and indirectly through synergistically increasing the release of somatostatin. Additionally, HGH will negatively feedback into the hypothalamus, thus decreasing GHRH production. The net effect of this regulatory mechanism produces a pulsatile release of HGH into circulation that varies hourly. In general, HGH levels will be increased in childhood, spike to their highest levels during puberty, and subsequently decrease with increased age.[3][4][5]

HGH has two mechanisms of effect: direct action and indirect action. The direct effects of HGH on the body are through its action on binding to target cells to stimulate a response. The indirect effects occur primarily by the action of insulin-like growth factor-1, which hepatocytes primarily secrete in response to elevated HGH binding to surface receptors. Once activated, the Janusactivating tyrosine kinases (JAKs) 1 and 2 will bind to the latent cytoplasmic transcriptions factors STAT1, STAT3, and STAT5, and be transported into the nucleusinducingincreased gene transcription and metabolism to produce insulin-like growth factor-1 for release into the circulation. Insulin-like growth factor-1 then has an impact on the growth and metabolism of peripheral tissues. One can think of the effects of HGH as a combined effect of both HGH and insulin-like growth factor-1.

Growth

HGH induces growth in nearly every tissue and organ in the body. However, it is most notorious forits growth-promoting effect on cartilage and bone, especially in the adolescent years. Chondrocytes and osteoblasts receive signals to increase replication and thus allow for growth in size via HGHs activation of the mitogen-activated protein (MAP) kinases designated ERKs (extracellular signal-regulated kinases) 1 and 2 cellular signaling pathways. Activation of this phosphorylation intracellular signaling cascade results in a cascade of protein activation, which leads to increased gene transcription of the affected cells and ultimately causes increased gene replication and cellular growth.

Insulin-like growth factor-1 binds to its receptor, IGF-1R, on the cellular surface and activates a tyrosine kinase-mediated intracellular signaling pathway that phosphorylates various proteins intracellularly leading to increased metabolism, anabolism, and cellular replication and division. Furthermore, it acts to inhibit apoptosis of the cell, thus prolonging the lifespan of existing cells. The net result is to encourage the growth of tissue and to create a hyperglycemic environment in the body.

Metabolic Effects

HGH impacts metabolism primarily by up-regulating the production of insulin-like growth factor-1 and its subsequent effect on peripheral cells. The intracellular signaling activation that occurs, as stated above, also has a significant impact on the basal metabolic functions of organ tissues. In general, cells enter an anabolic protein state with increased amino acid uptake, protein synthesis, and decreased catabolism of proteins. Fats are processed and consumed by stimulating triglyceride breakdown and oxidation in adipocytes. Additionally, HGH suppresses the ability of insulin to stimulate the uptake of glucose in peripheral tissues and causes an increased rate of gluconeogenesis in the liver, leading to an overall hyperglycemic state.[6][7][8]

Due to the pulsatile nature of HGH levelsfound in the blood, conventional measurements of serum HGH arealmost useless because the valuesmay vary from undetectable to extremely high depending on environmental stressors and conditions. If a clinician suspects HGH deficiency, it is best to evaluate insulin-like growth factor I and insulin-like growth factor binding protein-3 levels and to perform HGH stimulation tests.

In an HGH stimulation test, the patient fasts overnight, and a pharmacological challenge is added in the morning with either L-dopa, clonidine,propranolol,glucagon,arginine, or insulin-induced hypoglycemia. HGH serum levels are then evaluated hourly for a response to increased hormone levels. Failure of this test to increase HGH levels, therefore, indicates HGH deficiency.[9][10]

HGH is extremely importantfor modulating growth during adolescence. Therefore, the major aberrations in the regulation of HGH may result in growth defects. HGH hypersecretion results in gigantism or acromegaly, whereas HGH deficiencywill result in a growth deficit in children and the GH deficiency syndrome in adults.

Acromegaly

Acromegaly typically results from an HGH secreting pituitary adenoma with an onset after the closure of the epiphyseal growth plates, typically in adulthood. Therefore, bone growth primarily affects flat bones such as the skull, mandible, sternum, hands, and feet. Often the presenting complaint isof hats or gloves not fitting anymore due to swelling of the hands and head. Because the illness is due to a pituitary mass, hypopituitarism may also develop with secondary reproductive disorders and visual symptoms. In addition to bony growth, there is the growth of myocardium resulting in biventricular concentric hypertrophy and subsequent heart failure in later disease. Because HGH counteracts the effects of insulin on glucose and lipid metabolism, diabetes mellitus type 2 and hyperlipidemia are strongly associated with this disease. Treatment consists of surgery and radiation therapy targeting the underlying adenoma as well as symptomatic relief of the secondary effects of HGH as above.

Gigantism

This illness is very similar to acromegaly in all aspects, except the underlying pituitary adenoma develops before the closure of long bone epiphysis. Therefore, bone growth occurs in long bones such as the tibia, fibula, femur, humerus, radius, and ulna. Since epiphyseal closure occurs before adulthood, this is typically an illness with an onset seen in children. The organ and metabolic impacts are similar to acromegaly.

HGH Deficiency

In children, idiopathic HGH deficiency is the most common. In adult-onset, HGH deficiency typically presents as a constellation of hypopituitary deficiencies. The triggering incident is typically a pituitary adenoma, most likely a prolactinoma. However, other treatments, such as radiation therapy or surgery, might be the cause. Childhood-onset is associated with decreased growth of all skeletal structures, leading to dwarfism.Adult-onset HGH deficiency is less easily diagnosed as it has no single identifying feature that is pathognomonic. Typically adults have decreased skeletal muscleand increased fat mass in visceral tissue as well as decreased bone density and remodeling, which leads to osteoporosis. Dyslipidemia and insulin resistance are prevalent, which lead to secondary cardiovascular dysfunction, depressed mood, increased anxiety, and a lack of energy.[11][12][13]

Visit link:
Physiology, Growth Hormone - StatPearls - NCBI Bookshelf


Nov 8

Sermorelin: A better approach to management of adult-onset …

Growth hormone replacement therapy (GHRT) using recombinant human growth hormone (rhGH) has been embraced by many age management practitioners as one of the most effective methods for opposing somatic senescence currently available. However, its routine use has been controversial because few clinical studies have been performed to determine the potential risks of long-term therapy. Also, certain medical and legal issues have not been resolved causing some practitioners to restrict their use of the product. Some of these issues include the fact that:

Improper dosing can lead to side effects that may be serious in some patients,

Injection of hGH creates unnatural conditions of exposure to the hormone that may erode normal physiology,

The Code of Federal Regulations specifically forbids the use of rhGH in adults except for treatment of AIDS or human growth hormone deficiency (GHD) diagnosed pursuant to regularly accepted guidelines.

While there is a wealth of information showing that long-term administration of rhGH reduces intrinsic disease and extends life in adults suffering pathogenic GHD, consensus on whether extrapolation of those data to the aging condition is justified has not been reached (Perls et al 2005). Most of the major concerns derive from the fact that rhGH is mitogenic and may awaken latent cancers, that improper dose selection may promote metabolic disorders such as diabetes, and perhaps that pharmacological presentation may exacerbate decline of endocrine function by distorting essential hormonal interactions. Of course, all these concerns are speculative and will not be resolved until sufficient scientific evidence for or against GHRT eventually accumulate. In the interim, the value of rhGH in GHRT will continue to be debated; unfortunately based more upon personal prejudice than objective information.

Despite the eventual outcome to the Great Hormone Debate as it has been titled in media articles (Landsmann 2006), certain negative aspects of GHRT using rhGH cannot be disputed and justify searching for a better alternative. For example, square wave or pharmacological presentation of the exogenous hormone cannot be avoided since it is administered as a bolus, subcutaneous injection. Since the amount of rhGH entering the general circulation is not controlled by normal feedback mechanisms, tissue exposure to elevated concentrations is persistent and eventually may lead to tachyphylaxis and reduced efficacy. Also, because the body cannot modulate tissue exposure to rhGH, the practitioner is required to best guess the appropriate dosage based upon little other than serum measurements of insulin-like growth factor-1 (IGF-1) and subjective comments from the patient about perceived responses to the hormone. Thus, it would seem that an alternative method(s) of GHRT that circumvented these problems would be of great value so long as it retained the positive attributes of rhGH.

One possibility that is receiving growing attention is the use of GH secretagogues to promote pituitary health and function during aging. An example of such molecules is growth hormone releasing factor 129 NH2-acetate, or sermorelin, that recently became available to practitioners for use in longevity medicine (Merriam et al 2001). Other alternatives include orally active growth hormone-releasing peptides that are currently being developed by pharmaceutical companies. Some of these have been reported to be effective at improving physical performance in the elderly (Fahy 2006). However, it is unlikely that they will be marketed for several years. On the other hand, sermorelin, an analog of naturally occurring growth hormone-releasing hormone (GHRH) whose activity declines during aging, may presently offer a more immediate and better alternative to rhGH for GHRT in aging (Russell-Aulet et al 2001). The molecule was commercially produced and marketed for many years as an alternative to rhGH for use in children with growth retardation, but it could not compete with rhGH and was withdrawn as a therapeutic entity by the manufacturer. Paradoxically sermorelin failed as a growth-promoting agent in children for the very reason that it is a better alternative for GHRT in aging adults. Growth-deficient children need higher doses of growth hormone than can be achieved by stimulating production of their own hormone, whereas the beneficial effects of sermorelin on pituitary function and simulation of youthful growth hormone secretory dynamics in aging adults have little effect on growth rate in children. Unlike exogenous rhGH that causes production of the bioactive hormone IGF-1 from the liver, sermorelin simulates the patients own pituitary gland by binding to specific receptors to increase production and secretion of endogenous hGH. Because sermorelin increases endogenous hGH by stimulating the pituitary gland, it has certain physiological and clinical advantages over hGH that include:

Effects are regulated by negative feedback involving the inhibitory neurohormone, somatostatin, so that unlike administration of exogenous rhGH, overdoses of endogenous hGH are difficult if not impossible to achieve,

Because of the interactive effects of sermorelin and somatostain, release of hGH by the pituitary is episodic or intermittent rather than constant as with injected rhGH.

Tachphylaxis is avoided because sermorelin-induced release of pituitary hGH is not square wave, but instead simulates more normal physiology,

Sermorelin stimulates pituitary gene transcription of hGH messenger RNA, increasing pituitary reserve and thereby preserving more of the growth hormone neuroendocrine axis, which is the first to fail during aging (Walker et al 1994).

Pituitary recrudescence resulting from sermorelin helps slow the cascade of hypophyseal hormone failure that occurs during aging thereby preserving not only youthful anatomy but also youthful physiology (Villalobos et al 1997).

Finally, there is the question of lawful practice. Unlike rhGH which has legal restrictions on its clinical use, the off-label prescribing of sermorelin is not prohibited by federal law. Thus, it can be carefully employed and evaluated by the practitioner to objectively determine whether it provides greater benefits with less risk to his/her patients. In support of this effort, the Society for Applied Research in Aging will be providing sermorelin free of cost on a competitive basis to practitioners willing to study its effects under protocol conditions and to report the outcomes in a peer-reviewed journal such as Clinical Interventions in Aging. Hopefully, through such efforts we can contribute to development of a paradigm for evidence-based GHRT in clinical age management.

For more information on this effort and to participate in the protocol, please contactmoc.sserpevod@nileromres.

Continue reading here:
Sermorelin: A better approach to management of adult-onset ...


Nov 8

HGH temporarily cuts operating room and birthing centre capacity in half – The Review Newspaper

Hawkesbury and District General Hospital (HGH) has announced a temporary reduction in services as a result of a serious clinical staffing shortage. According to a statement issued by HGH, effective November 1, 2021, two departments areoperating at 50 per cent capacity: Perioperative Services (operating rooms) and the Family Birthing Centre. Other inpatient care and outpatient services will continue to operate at planned service levels.

The decision followed a detailed analysis and forecasts of activity levels and staffing capacity, as well as consultations with several healthcare leaders.

The nursing shortage has become an urgent issue in Ontario and across the countrys healthcare system. Our unique geographical location and the language needs of HGH patients make the staffing situation even more challenging. As Chief Executive Officer, I made the difficult decision in order to manage the risks to patients and for the well-being of the clinical and medical staff, said HGH CEO Marc LeBoutillier. The HGH Board of Directors unanimously supported this decision at its October 27 meeting.

Surgeries and procedures to be postponed and the decrease in the Family Birthing Centre activities will be selected on a set of clear criteria, including, among others, an ethical framework and consideration of the healthcare needs of the patients. The Hospital will notify patients directly affected by this reduction in services.

This decision was carefully weighed and taken to ensure the safety of patients and staff. Our teams of clinical staff and physicians are doing their best to reduce the impacts on expecting mothers, patients awaiting treatment and their families, explained HGH Chief of Staff, Dr. Julie Maranda.

We are doing our utmost to balance urgent and elective patient care for our community.

HGH urges anyone needing urgent care to come to the Emergency Department. We would like to thank our community for their support, and all healthcare workers for their continued hard work and dedication throughout the pandemic and during these exceptional times, said LeBoutillier.

HGH has not given a specific reason for the serious clinical staffing shortage. The Review contacted the hospital on November 2 seeking furtherinformation,but no response was received by publication time.

A policy requiring mandatory COVID-19 vaccination for all HGH employees took effect on October 15. On October 9, HGHVice President, Human Resources and Corporate ServicesGisleLarocque stated 100 per cent of HGH physicians were vaccinated and 88.1 per cent of all other hospital staff. Larocque anticipated 99.1 of all HGH employees would be vaccinated by October 15.

Read this article:
HGH temporarily cuts operating room and birthing centre capacity in half - The Review Newspaper


Nov 8

The Next Derrick Henry Is 6 Years Old And Giving Out Stiff Arms Like Halloween Candy – Barstool Sports

Someone needs to get this highlight reel to Chris Berman ASAmotherfuckingP because I need to hear the sound effects that comes out of Boomer's mouth as this purple tank ran wild on the gridiron and crushed the souls of countless 1st graders who will never want to play a down of football again. Even Spike didn't put up that kind of tape against the Little Giants and he was a football machine fueled by HGH in a run-first offense facing off against a bunch of undersized misfits. Purple 6 here displayed all that power along with the kind of balance at the end of this run that separates the immortals from the legends.

I know people don't like using first round draft picks on running backs and I don't know what type of Red Auerbach tomfoolery has to be done to get this toddler Tractorcito signed to an NFL roster more than a decade before he's eligible to play. However if I were an NFL GM, I'd draft this kid with the first pick I had and worry about the rest later considering we had people firing off takes that Derrick Henry was the most important player in FOOTBALL as recently as last week and you don't teach that type of dominance over your peers regardless of age.

This video may have put the kid on the map but his high school numbers will put him at the top of every Big Board long before he plays a snap of college football, almost definitely for Nick Saban who will have just signed another 10 year deal at Bama after drinking whatever blood he drinks to stay young.

As for all the other kids that attempted to tackle this monster in what was likely their last game of pee wee football due to that soul crushing, I have only three words for you

Follow this link:
The Next Derrick Henry Is 6 Years Old And Giving Out Stiff Arms Like Halloween Candy - Barstool Sports


Aug 31

Heartland Group Holdings’ (NZSE:HGH) one-year earnings growth trails the respectable shareholder returns – Simply Wall St

Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly boost your returns by picking above-average stocks. For example, the Heartland Group Holdings Limited (NZSE:HGH) share price is up 84% in the last 1 year, clearly besting the market return of around 8.4% (not including dividends). If it can keep that out-performance up over the long term, investors will do very well! The longer term returns have not been as good, with the stock price only 30% higher than it was three years ago.

The past week has proven to be lucrative for Heartland Group Holdings investors, so let's see if fundamentals drove the company's one-year performance.

View our latest analysis for Heartland Group Holdings

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

During the last year Heartland Group Holdings grew its earnings per share (EPS) by 20%. The share price gain of 84% certainly outpaced the EPS growth. So it's fair to assume the market has a higher opinion of the business than it a year ago.

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

We know that Heartland Group Holdings has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Heartland Group Holdings will grow revenue in the future.

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Heartland Group Holdings, it has a TSR of 93% for the last 1 year. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the total shareholder return.

It's nice to see that Heartland Group Holdings shareholders have received a total shareholder return of 93% over the last year. That's including the dividend. That gain is better than the annual TSR over five years, which is 15%. Therefore it seems like sentiment around the company has been positive lately. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 3 warning signs we've spotted with Heartland Group Holdings (including 1 which is concerning) .

We will like Heartland Group Holdings better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on NZ exchanges.

When trading stocks or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. *Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Visit link:
Heartland Group Holdings' (NZSE:HGH) one-year earnings growth trails the respectable shareholder returns - Simply Wall St


Aug 31

Elite HRT Publishes Informational Packet on Testosterone Replacement Therapy – Business Wire

MIAMI--(BUSINESS WIRE)--The trained advisors at Elite HRT have published new informational guidance on one of their most-popular services, Testosterone Replacement Therapy (TRT). How To Get TRT: What Is Testosterone Replacement Therapy? is a free online resource intended to educate the general public on what testosterone does within the body, and the benefits that can be seen by introducing some as natural supplies diminish with age.

Testosterone is traditionally known as a masculine hormone, as it helps balance male reproductive functions as well as mood balancing, bone health, muscle mass, body fat composition, and blood. It should be noted that this element is present in female bodies, but at much lower levels. Still, it can impact their mood, sexual desire, and other functions. TRT is the process of supplying the body with additional testosterone to increase libido, energy, and motivation. This therapy can result in a decrease of body fat and increase in both muscle strength and athletic performance, while also boosting mood and mental clarity. However, these benefits can vary from person to person, and anyone wanting to try testosterone replacement therapy should speak with a professional before starting.

This article is provided online for public consumption, as HRT works to spread awareness of these available hormone therapies so more people can pursue the treatment they need in order to lead better lives. The article was reviewed by Medical Advisor and Regulatory Affairs Specialist Camille Freking to verify the accuracy and honesty of its claims.

About Elite HRT: Elite HRT is a telemedicine firm led by a network of physicians specializing in hormone replacement therapies. With unique approaches to HRT, TRT, HGH, and more, Elite HRT works to tailor solutions uniquely created for specific patients, all at affordable rates. Those wanting to learn more and contact Elite HRT can visit https://www.elitehrt.com/ and submit a contact request form with background information today.

Read more:
Elite HRT Publishes Informational Packet on Testosterone Replacement Therapy - Business Wire


Aug 31

[PDF] Hormone Replacement Therapy Market to Reflect Steady Growth and Future Scope UNLV The Rebel Yell – UNLV The Rebel Yell

One of the key factors fueling the growth of the global hormone replacement therapy market is increasing acquisitions. Pfizer Inc., a pharmaceutical firm headquartered in the United States, combined with OPKO Health Inc., a business based in the U.S., in 2014 to create a long-acting growth hormone (hGH-CTP) and novel therapies for growth hormone deficient individuals. hGH-CTP is more convenient since patients just require one injection each week instead of daily dosages. In the U.S. and Europe, hGH-CTP has been designated as an orphan medication for children and adults with growth hormone deficiencies.

The expansion of the global hormone replacement therapy market is projected to be aided by a strong pipeline. In 2017, Novo Nordisk A/S, a Danish firm, completed phase 3 clinical studies for Somapacitan. This medication is used to treat adult testosterone deficiency.

FREE | Request Sample is Available @https://www.coherentmarketinsights.com/insight/request-sample/2079

*The Sample only consist ofTable of Content (ToC).Research Frameworkof the actual report.Research Methodologyadopted for it.

Major Company Profiles Covered in This Report:Novartis AG, Abbott Laboratories, Mylan N.V., Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company.

The market for hormone replacement treatment is projected to expand due to the rising prevalence of various chronic diseases.

The market for hormone replacement treatment is projected to expand due to the rising prevalence of hypogonadism in adult males throughout the world. Hypogonadism affects 2.1 percent to 12.8 percent of middle-aged men, according to the European Association of Urologys 2016 study. In Europe, the prevalence of low testosterone and hypogonadism symptoms in males aged 40 to 79 ranges from 2.1 percent to 5.7 percent.

The expansion of the global hormone replacement therapy market is projected to be aided by easier access and government assistance for research and development efforts. NGOs such as the National Gaucher Society provide financial assistance to patients who require expensive insulin replacement treatment.

Request Free research report Brochure @https://www.coherentmarketinsights.com/insight/request-pdf/2079

Companies are concentrating their efforts on creating generic versions of numerous medications for the treatment of diseases that are more common in women, such as hypothyroidism. On July 24, 2017, Teva Pharmaceutical Industries Ltd. introduced a generic version of Vagifem, 10 mcg, in the United States. Estradiol vaginal inserts are a kind of oestrogen used to treat atrophic vaginitis caused by menopause.

Furthermore, Mylan N.V. received FDA clearance for its Abbreviated New Medication Application (ANDA) for Estradiol Vaginal Cream USP, 0.01 percent on December 29, 2017, and therefore marketed the drug in the U.S. This cream is the first generic alternative to Allergans Estrace Cream, which is used to treat vulvar and vaginal atrophy.

Mylan is one of the few firms that sells Estradiol in cream, gel, transdermal patch, and tablet form. This will benefit both healthcare personnel and patients, as well as ensuring the businesss long-term viability.

Major companies contributing in the global hormone replacement therapy market are Pfizer Inc., QuatRx Pharmaceuticals, Mylan N.V., Abbott Laboratories, Amgen, Inc., Novartis AG, Eli Lilly and Company, Bayer AG, Merck KgaA, Teva Pharmaceutical Industries Ltd., and Novo Nordisk A/S.

Inquire more about this report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2079

Some Notable Offerings by Coherent Market Insights Report on Hormone Replacement Therapy market:

We will provide you an analysis of the extent to which this Hormone Replacement Therapy market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.

We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.

Also, this report will help you to identify any trends to forecast growth rates.

The analyzed report will forecast the general tendency for supply and demand.

Also, Research Report Examines:

Competitive companies and manufacturers in global market

By Product Type, Applications & Growth Factors

Industry Status and Outlook for Major Applications / End Users / Usage Area

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Read the original:
[PDF] Hormone Replacement Therapy Market to Reflect Steady Growth and Future Scope UNLV The Rebel Yell - UNLV The Rebel Yell


Aug 5

Human Growth Hormone (HGH) Market SWOT Analysis by Size, Status and Forecast to 2021-2027 The Manomet Current – The Manomet Current

The latest independent research document on Global Human Growth Hormone (HGH) examine investment inMarket. It describes how companies deploying these technologies across various industry verticals aim to explore its potential to become a major business disrupter. The Human Growth Hormone (HGH) study eludes very useful reviews & strategic assessment including the generic market trends, emerging technologies, industry drivers, challenges, regulatory policies that propel the market growth, along with major players profile and strategies. This version of Human Growth Hormone (HGH) market report advocates analysis of Sandoz International, Ipsen, GeneScience Pharmaceuticals, Anhui Anke Biotechnology (Group), BioPartners, Ferring Pharmaceuticals, F. Hoffmann-La Roche, Novo Nordisk, Merck Serono, LG Life Sciences, Teva Pharmaceutical Industries, Eli Lilly & Pfizer.

Get Free Sample Pages of Global Human Growth Hormone (HGH) Market Study Now @:https://www.htfmarketreport.com/sample-report/3399826-2020-2025-global-human-growth-hormone

As Human Growth Hormone (HGH) research and application [Growth Hormone Deficiency, Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age & SHOX Deficiency] continues to expand in scope, the market will see deeper integration and application of more technologies in the future. This commercialization of market is playing a positive role in accelerating Human Growth Hormone (HGH) business digitalization, improving industry chain structures and enhancing information use efficiency. The findings mainly focus on category or product type: , Powder & Solvent etc, which underpins many recent advances in the other Human Growth Hormone (HGH) technologies.

In order to provide a more informed view, Human Growth Hormone (HGH) research offers a snapshot of the current state of the rapidly changing industry, looking through the lenses of both end users and service provides/players ofto come up with a more robust view.

Market Scope

Based on the type of product, themarket segmented into :, Powder & Solvent

Based on the End use application, themarket segmented into :Growth Hormone Deficiency, Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age & SHOX Deficiency

Buy this research report @https://www.htfmarketreport.com/buy-now?format=1&report=3399826

Regional Landscape

Geographically, the Human Growth Hormone (HGH) market size by revenue is broken down by 18+ countries fromNorth America, LATAM, the Middle East, Asia Pacific, Africa, and Europebased on various characteristics such as geographic footprints and business operation locations of players.

Analysts at HTF MI sheds light on Human Growth Hormone (HGH) market data by Country

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, South Korea, Thailand, India, Indonesia, Australia and Others)Europe (Germany, Russia, the UK, Italy, France, Spain, Belgium, Netherlands, Switzerland, Nordic Nations, Rest of Europe.)North America (the United States, Mexico, and Canada)South America (Brazil, Argentina, Chile, Rest of South America)Middle East and Africa (GCC Countries, Turkey, Israel, South Africa, Egypt and Rest of MEA)

The Human Growth Hormone (HGH) study cites various market development activities and business strategies such as new product/services development, Joint Ventures, partnerships, mergers and acquisitions, etc that Industry players such as Sandoz International, Ipsen, GeneScience Pharmaceuticals, Anhui Anke Biotechnology (Group), BioPartners, Ferring Pharmaceuticals, F. Hoffmann-La Roche, Novo Nordisk, Merck Serono, LG Life Sciences, Teva Pharmaceutical Industries, Eli Lilly & Pfizer are utilizing to overcome macro-economic scenarios. The Human Growth Hormone (HGH) Market company profiles include Business Overview, Product / Service Offerings, SWOT Analysis, Segment & Total Revenue, Gross Margin and % Market Share.

Not Matching with Business Objective? Enquire for Customize Report @https://www.htfmarketreport.com/enquiry-before-buy/3399826-2020-2025-global-human-growth-hormone

Extracts from Global Human Growth Hormone (HGH) Market Study

1. Market Snapshot2. Global Human Growth Hormone (HGH) Market Factor Analysis Value Chain Analysis Growth Drivers, Trends and Challenges Porters 5- Forces Analysis PESTEL Analysis3.Human Growth Hormone (HGH) Market by Type (2016-2026) [, Powder & Solvent]4. Market by Applications/ End Users (2016-2026) [Growth Hormone Deficiency, Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age & SHOX Deficiency]5.Human Growth Hormone (HGH) Market: Country Landscape6. Market Size Breakdown for Each Country7. Competitive Landscape Market Share Analysis by Players Company Profiles

.. Continued

Data Sources & Methodology

The primary sources involve the industry experts from the Global Human Growth Hormone (HGH) Market including the management organizations, processing organizations, service providers of the industrial value chain. In the extensive research process undertaken for this study, the primary sources considered such as Postal Surveys, telephone, Online & Face-to-Face Survey to obtain and verify both qualitative and quantitative aspects. When it comes to secondary sources Companys Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were used.

Read Detailed Index of full Research Study at @https://www.htfmarketreport.com/reports/3399826-2020-2025-global-human-growth-hormone

Thanks for reading Human Growth Hormone (HGH) Industry research publication; you can opt for regional report version like Western Europe, USA, China, Southeast Asia, LATAM, APAC etc. Also, we can serve you with customize research services as HTF MI holds a database repository that includes Public organizations and Millions of Privately held companies with expertise across various Industry domains.

About Author:HTF Market Intelligence consulting is uniquely positioned empower and inspire with research and consulting services to empower businesses with growth strategies, by offering services with extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist in decision making.

Contact US:Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218sales@htfmarketreport.com

Connect with us atLinkedIn|Facebook|Twitter

See the rest here:
Human Growth Hormone (HGH) Market SWOT Analysis by Size, Status and Forecast to 2021-2027 The Manomet Current - The Manomet Current



Page 3«..2345..1020..»